Clinical significance of c-myc and p53 expression in head and neck squamous cell carcinomas

Cancer Detection and Prevention

Volumn 28, Issue 3, 2004, Pages 178-186

  Waitzberg, Angela F L ^a   Nonogaki, Suely ^b   Nishimoto, Inês N ^c   Kowalski, Luiz P ^c   Miguel, Roberto E V ^c   Brentani, Ricardo R ^d   Brentani, M M ^e  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO ADOLFO LUTZ   (Brazil)

^c A C CAMARGO CANCER CENTER   (Brazil)

^d LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

c myc; Head and neck tumors; p53; Survival analysis

Indexed keywords

PROTEIN P53; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER STAGING; COMPARATIVE STUDY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HEAD AND NECK TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; MORTALITY; NEEDLE BIOPSY; ONCOGENE MYC; PATHOLOGY; PROBABILITY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; SURVIVAL;

ADULT; AGED; BIOPSY, NEEDLE; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; PROBABILITY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 3042593782     PISSN: 0361090X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cdp.2004.02.003     Document Type: Article

References (36)

1. Vokes E.E., Weichsebaum R.R., Lippaman S.M., Kilong W. Head and neck cancer. New Engl. J. Med. 328:1993;184-194
2. Brazilian Health Ministry, Estimativas da incidência e mortalidade por câncer do Brasil. Instituto Nacional do Câncer IINCA), Ministério da Saúde, Brasil; 2002.
3. Kim E.S., Glisson B.S. Treatment of metastatic head and neck cancer: chemotherapy and novel agents. Cancer Treat Res. 114:2003;295-314
4. Quon H., Liu F.F., Cummings B.J. Potential molecular prognostic markers in head and neck squamous cell carcinomas. Head Neck. 23:2001;147-159
5. Nesbit C.E., Tersak J.M., Prochownik E.V. MYC oncogenes and human neoplastic disease. Oncogene. 18:1999;3004-3016
6. Agarwal M.L., Taylor W.R., Chernov M.V., Chernova O.B., Stark G.R. The p53 network. J. Biol. Chem. 273:1998;1-4
7. Wagner A.J., Kokontis J.M., Hay N. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. Genes Dev. 8(23):1994;2817-2830
8. Hermeking H., Eick D. Mediation of c-myc-induced apoptosis by p53. Science. 265:1994;2091-2093
9. Riviere A., Wilckens C., Loning T. Expression of c-erb B2 and c-myc in squamous epithelia and squamous cell carcinomas of the head and neck and the lower female genital tract. J. Oral Pathol. Med. 19:1993;408-413
10. Reyt E., Lavielle J.P., Brambilla E., Barra Y., Riva C. Expression of oncogenes C-myc, C-raf, and N-ras in advanced cancers of the upper respiratory and digestive tracts. Correlation with tumor clinical response to chemotherapy. Ann. Otolaryngol. Chir. Cervicofac. 110:1993;310-315
11. Riva C., Lavielle J.P., Reyt E., Brambilla E., Lunardi J., Brambilla C. Differential c-myc, c-jun, c-raf and p53 expression in squamous cell carcinoma if the head and neck: implication in drug and radioresistence. Oral Oncol. J. Cancer. 31:1995;384-391
12. Field J.K., Spandidos D.A., Stell P.M., Vaughan E.D., Evan G.I., Moore J.P. Elevated expression of the c-myc oncoprotein correlates with poor prognosis in head and neck squamous cell carcinoma. Oncogene. 4:1989;1463-1468
13. Sakai H., Kawano K., Okamura K., Hashimoto N. Immunohistochemical localization of c-myc oncogene product and EGF receptor in oral squamous cell carcinoma. J. Oral Pathol. 19:1990;1-4
14. Eversole L.R., Sapp L.R. c-myc oncoprotein expression in oral precancerous and early cancerous lesion. Eur. J. Cancer Oral Oncol. 29:1993;131-135
15. Porter M.J., Field J.K., Leung S.F., et al. The detection of the c-myc and ras oncogenes in nasopharyngeal carcinoma by immunohistochemistry. Acta Otolaringol. 114:1994;105-119
16. Gapany M., Pavelic Z.P., Kelley D.J., et al. Immunohistochemical detection of c-myc protein in head and neck tumors. Arch. Otolaryngol. Head Neck Surg. 120:1994;255-259
17. Merritt W.D., Weissler M.C., Turk B.F., Gilmer T.M. Oncogene amplification in squamous cell carcinoma of the head and neck. Arch. Otolaryngol. Head Neck. 116:1990;1394-1398
18. Leonard J.H., Kearsley J.H., Chenevix-Trench G., Hayward N.K. Analysis of gene amplification in head and neck squamous cell carcinomas. Int. J. Cancer. 48:1991;511-515
19. Haughey B.H., Von Hoff D.D., Windle B.E., Wahl G.M., Mock P.M. C-myc oncogene copy number in squamous cell carcinoma of the head and neck. Am. J. Otolaryngol. 1393:1992;168-171
20. Rodrigo J.P., Lazo P.S., Ramos S., Lazo P.S., Alvarez I., Suarez C. Myc amplification in squamous cell carcinomas of the head and neck. Arch. Otolaryngol Head Neck Surg. 122:1996;504-507
21. Schraml P., Kononen J., Bubendorf L., et al. Tissue microarrays for gene amplification surveys in many different tumor types. Clin. Cancer Res. 5:1999;1966-1975
22. de la Guardia C., Casiano C.A., Trinidad-Pinedo J., Baez A. CENP-F gene amplification and overexpression in head and neck squamous cell carcinomas. Head Neck. 23:2001;104-112
23. Freier K., Joos S., Flechtenmacher C., et al. Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma. Cancer Res. 63(6):2003;1179-1182
24. Bergamo N.A., Rogatto S.R., Poli-Frederico R.C., et al. Comparative genomic hybridization analysis detects frequent over-representation of DNA sequences at 3q, 7p, and 8q in head and neck carcinomas. Cancer Genet. Cytogenet. 119(1):2000;48-55
25. Squire J.A., Bayani J., Luk C., et al. Molecular cytogenetic analysis of head and neck squamous cell carcinoma: by comparative genomic hybridization, spectral karyotyping, and expression array analysis. Head Neck. 24:2002;874-886
26. Califano J., van der Riet P., Westra W., et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res. 56:1996;2488-2492
27. Nylander K., Dabelsteen E., Hall P.A. The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck. Oral. Pathol. Med. 29:2000;413-425
28. Baral R., Patnaik S., Das B.R. Co-overexpression of p53 and c-myc proteins linked with advanced stages of betel- and tobacco-related oral squamous cell carcinomas from eastern India. Eur. J. Oral Sci. 106:1998;907-913
29. Broders A.C. The microscopic grading of cancer. S. Clin. North Am. 21:1941;947-962
30. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:1958;457-481
31. Loke S.L., Neckers L.M., Schwab G., Jaffe E. c-myc protein in normal tissue Effects of fixation no its apparent sub-cellular distribution. Am. J. Pathol. 131:1988;29-37
32. Waikel R.L., Wang X.-J., Roop D.R. Targeted expression of c-myc in the epidermis alters normal proliferation, differentiation and UV-B induced apoptosis. Oncogene. 18:1999;4870-4878
33. Pelengaris S., Littlewood T., Khan M., Elia G., Evan G. Reversible activation of c-myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion. Mol. Cell. 3:1999;565-577
34. Geisler S.A., Olshan A.F., Weissler M.C., et al. p16 and p53 protein expression as prognostic indicators of survival and disease recurrence from head and neck cancer. Clin. Cancer Res. 8:2002;3445-3453
35. Logullo A.F., de Moura R.P., Nonogaki S., Kowalski L.P., Nagai M.A., Simpson A.J. A proposal for the integration of immunohistochemical staining and DNA-based techniques for the determination of TP53 mutations in human carcinomas. Diagn. Mol. Pathol. 9:2000;35-40
36. Homann N., Nees M., Conradt C., et al. Overexpression of p53 in tumor-distant epithelia of head and neck cancer patients is associated with an increased incidence of second primary carcinoma. Clin. Cancer Res. 7:2001;290-296